Korenaga D, Baba H, Kakeji Y, Orita H, Haraguchi M, Maehara Y, Saku M, Sugimachi K
Second Department of Surgery, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Surg Oncol. 1991 Oct;48(2):136-41. doi: 10.1002/jso.2930480213.
To evaluate the benefit of R2 gastrectomy for gastric cancer in Japanese patients over 80 years of age, data on 93 patients who underwent gastrectomy between 1967 and 1989 were collected retrospectively from charts filed in the Kyushu University Hospital and two affiliated national hospitals. Of 93 patients, 62 had a localized tumor without evidence of metastatic spread. These 62 patients were classified into two groups according to the procedures performed: 35 underwent R1 gastrectomy and 27, R2 gastrectomy. The clinical and pathological characteristics of the patients in the two groups were comparable at the time of surgery, except that the group who underwent R1 gastrectomy was older. R2 gastrectomy involved a significantly longer operation time (P less than 0.01) and greater intraoperative blood loss (P less than 0.05) when compared to R1 gastrectomy, but no patient undergoing this extensive surgery died. The difference in the morbidity rate between the two groups was not statistically significant. The 5-year survival rate was 55.8% in the R1 group and 65.4% in the R2 group. When gastric cancer invaded the serosa and/or secondary nodes, a substantial increase in survival time was gained with R2 gastrectomy when compared to an R1 operation. These findings suggest that an R2 gastrectomy is feasible, even for patients over 80 years, but is indicated mainly when the carcinoma had invaded the serosa and/or secondary nodes and the patients are at good risk for major surgery.
为评估R2胃切除术对80岁以上日本胃癌患者的益处,我们从九州大学医院及两所附属国立医院存档的病历中,回顾性收集了1967年至1989年间接受胃切除术的93例患者的数据。93例患者中,62例有局限性肿瘤,无转移扩散证据。根据手术方式,将这62例患者分为两组:35例行R1胃切除术,27例行R2胃切除术。两组患者在手术时的临床和病理特征具有可比性,只是接受R1胃切除术的患者年龄更大。与R1胃切除术相比,R2胃切除术的手术时间明显更长(P<0.01),术中失血量更多(P<0.05),但接受这种广泛手术的患者均未死亡。两组的发病率差异无统计学意义。R1组的5年生存率为55.8%,R2组为65.4%。当胃癌侵犯浆膜层和/或区域淋巴结时,与R1手术相比,R2胃切除术可显著延长生存时间。这些结果表明,即使对于80岁以上的患者,R2胃切除术也是可行的,但主要适用于癌已侵犯浆膜层和/或区域淋巴结且患者具有较大手术风险的情况。